© Copyright 2026 American Medical Association. All rights reserved.
Anoscopy with directed submucosal injection of a bulking agent for fecal incontinence is a specialized medical procedure aimed at addressing passive fecal incontinence, which is often caused by internal anal dysfunction. This procedure utilizes an anoscope, a tubular instrument designed for visualizing the anal canal and rectum, to facilitate the precise delivery of a bulking agent into the submucosal tissue of the anus. The bulking agent, which may include substances such as hyaluronic acid/dextranomer or Solesta, serves as a space filler that enhances the structural integrity of the anal canal, thereby improving the ability to retain fecal matter. Prior to the injection, an evacuation enema may be administered to clear the rectal area, ensuring optimal conditions for the procedure. The injection process involves making a total of four 1 mL injections strategically placed above the dentate line into the four anal quadrants: posterior, left lateral, anterior, and right lateral. After the injections, the sites are carefully examined for any signs of bleeding before the anoscope is removed, concluding the procedure. This intervention is particularly beneficial for patients who experience involuntary loss of stool, providing a minimally invasive option to enhance anal function and improve quality of life.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.